HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹311 Cr | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr |
What is the latest Revenue of HESTER BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹311 Cr |
| Mar2024 | ₹305 Cr |
| Mar2023 | ₹266 Cr |
| Mar2022 | ₹235 Cr |
| Mar2021 | ₹214 Cr |
How is Revenue of HESTER BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹311 Cr | 2.15 | |
| Mar2024 | ₹305 Cr | 14.45 | |
| Mar2023 | ₹266 Cr | 13.23 | |
| Mar2022 | ₹235 Cr | 9.65 | |
| Mar2021 | ₹214 Cr | - | |
Compare Revenue of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,324.0 Cr | -1% | -2.3% | -33.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -1% |
-2.3% |
-33.1% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses